BTIS
IMGN

BB&T Investment Services’s Immunogen Inc IMGN Stock Holding History

BB&T Investment Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$0 Buy
175
+172
+5,733% +$1.06K ﹤0.01% 1492
2017
Q3 		$0 Buy
+3
New +$20 ﹤0.01% 1335

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BB&T Investment Services's IMGN Position: Q4 2017 in Review

BB&T Investment Services increased its Immunogen Inc (IMGN) stake by 5,733% in Q4 2017, buying an estimated $1.06K and bringing the position to 175 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

BB&T Investment Services first reported a position in IMGN in Q3 2017 and has held it in 2 quarters since. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • BB&T Investment Services held 175 shares of Immunogen Inc worth $0 as of Q4 2017.
  • BB&T Investment Services bought 172 Immunogen Inc shares in Q4 2017, an estimated $1.06K.
  • Immunogen Inc made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1492 holding.
  • BB&T Investment Services first reported a position in Immunogen Inc in Q3 2017 and has held it in 2 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.